No evidence for distinct types in the evolution of SARS-CoV-2

Abstract A recent study by Tang et al. claimed that two major types of severe acute respiratory syndrome-coronavirus-2 (CoV-2) had evolved in the ongoing CoV disease-2019 pandemic and that one of these types was more ‘aggressive’ than the other. Given the repercussions of these claims and the intense media coverage of these types of articles, we have examined in detail the data presented by Tang et al., and show that the major conclusions of that paper cannot be substantiated. Using examples from other viral outbreaks, we discuss the difficulty in demonstrating the existence or nature of a functional effect of a viral mutation, and we advise against overinterpretation of genomic data during the pandemic.

[1]  Justin C. Fay,et al.  Hitchhiking under positive Darwinian selection. , 2000, Genetics.

[2]  Kari Stefansson,et al.  Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.

[3]  T. Nyenswah,et al.  Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models. , 2018, Cell reports.

[4]  Sung Keun Kang,et al.  Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. , 2004, Science.

[5]  Colin Renfrew,et al.  Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.

[6]  Andrew Rambaut,et al.  Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic , 2020, Nature Microbiology.

[7]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[8]  S. Higgs,et al.  Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes , 2011, Proceedings of the National Academy of Sciences.

[9]  M. Sircar,et al.  Pneumonia of unknown cause. , 1990, The European respiratory journal.

[10]  Gavin J. D. Smith,et al.  Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2 , 2020, mBio.

[11]  E. Muths,et al.  Exploring the amphibian exposome in an agricultural landscape using telemetry and passive sampling , 2018, Scientific Reports.

[12]  Xiang Li,et al.  On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.

[13]  Gavin J. D. Smith,et al.  Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity , 2019, Proceedings of the National Academy of Sciences.

[14]  S. Buchbinder,et al.  Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). , 2000, AIDS research and human retroviruses.

[15]  V. Nerurkar,et al.  Evidence for a "Founder Effect" among HIV-infected injection drug users (IDUs) in Pakistan , 2010, BMC infectious diseases.

[16]  Joshua B. Singer,et al.  GLUE: a flexible software system for virus sequence data , 2018, BMC Bioinformatics.

[17]  Edward C. Holmes,et al.  Human Adaptation of Ebola Virus during the West African Outbreak , 2016, Cell.

[18]  T. Lam,et al.  Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic , 2020, Nature Microbiology.

[19]  D. Heckerman,et al.  Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.

[20]  Peter D. Keightley,et al.  Inferring the Probability of the Derived vs. the Ancestral Allelic State at a Polymorphic Site , 2018, Genetics.

[21]  Nuno R. Faria,et al.  A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage , 2020, medRxiv.

[22]  David L. Robertson,et al.  Human immunodeficiency virus: Phylogeny and the origin of HIV-1 , 2001, Nature.

[23]  Sewall Wright,et al.  Statistical genetics and evolution , 1942 .

[24]  Zhongming Zhao,et al.  Moderate mutation rate in the SARS coronavirus genome and its implications , 2004, BMC Evolutionary Biology.

[25]  Sergei L. Kosakovsky Pond,et al.  Synonymous Site-to-Site Substitution Rate Variation Dramatically Inflates False Positive Rates of Selection Analyses: Ignore at Your Own Peril , 2020, Molecular biology and evolution.

[26]  Simon Whelan,et al.  Statistical Methods in Molecular Evolution , 2005 .

[27]  Hannah Stower.  Spread of SARS-CoV-2 , 2020, Nature Medicine.

[28]  Jennifer L. Gardy,et al.  Towards a genomics-informed, real-time, global pathogen surveillance system , 2017, Nature Reviews Genetics.

[29]  Chi-Hung Lin,et al.  Open Reading Frame 8a of the Human Severe Acute Respiratory Syndrome Coronavirus Not Only Promotes Viral Replication but Also Induces Apoptosis , 2007, The Journal of infectious diseases.

[30]  Gavin J. D. Smith,et al.  Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2 , 2020, bioRxiv.

[31]  Guoping Zhao,et al.  Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China , 2004, Science.

[32]  A. Pfeifer,et al.  Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission , 2018, Scientific Reports.

[33]  Ziheng Yang.  PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.

[34]  Sergei L. Kosakovsky Pond,et al.  HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..

[35]  Pardis C. Sabeti,et al.  Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic , 2016, Cell.

[36]  Trevor Bedford,et al.  MERS-CoV spillover at the camel-human interface , 2017, bioRxiv.

[37]  Edward C. Holmes,et al.  A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.

[38]  T. Fung,et al.  Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3 , 2017, Virology.